Bath & Body Works (WBO:LBRA) Cash Conversion Cycle: 35.60 (As of Apr. 2026)


WBO:LBRA Bath & Body Works Inc WBO:LBRA
62 GF Score
Price €18.79
GF Value €29.16
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Bath & Body Works Cash Conversion Cycle?

Bath & Body Works WBO:LBRA -4.01% 62 Cash Conversion Cycle is 35.60 as of Apr. 2026. GuruFocus rates WBO:LBRA with a GF Score™ of 62/100 and a GF Value™ of €29.16 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Bath & Body Works's Days Sales Outstanding for the three months ended in Apr. 2026 was 9.18.
Bath & Body Works's Days Inventory for the three months ended in Apr. 2026 was 85.24.
Bath & Body Works's Days Payable for the three months ended in Apr. 2026 was 58.82.
Therefore, Bath & Body Works's Cash Conversion Cycle (CCC) for the three months ended in Apr. 2026 was 35.60.


Bath & Body Works  (WBO:LBRA) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Bath & Body Works Cash Conversion Cycle Related Terms


Bath & Body Works Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Bath & Body Works's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bath & Body Works Cash Conversion Cycle Chart

Bath & Body Works Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.72 32.80 36.66 42.23 40.74

Bath & Body Works Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.09 49.32 51.43 27.71 35.60

WBO:LBRA vs MNSO, RH, ASO: Cash Conversion Cycle Comparison

For the Specialty Retail subindustry, Bath & Body Works's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bath & Body Works Cash Conversion Cycle vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Bath & Body Works's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Bath & Body Works's Cash Conversion Cycle falls into.


WBO:LBRA
62GF Score
Bath & Body Works Inc WBO:LBRA
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bath & Body Works Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Bath & Body Works's Cash Conversion Cycle for the fiscal year that ended in Jan. 2026 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=10.33+68.17-37.76
=40.74

Bath & Body Works's Cash Conversion Cycle for the quarter that ended in Apr. 2026 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=9.18+85.24-58.82
=35.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 35.60 mean?
Bath & Body Works (WBO:LBRA) has a Cash Conversion Cycle of 35.60 as of Apr. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Bath & Body Works and its competitors.
Is Bath & Body Works' Cash Conversion Cycle too high?
Bath & Body Works' current Cash Conversion Cycle is 35.60. The Retail - Cyclical industry median Cash Conversion Cycle is 69.06. Bath & Body Works' value of 35.60 is 48.5% below this industry median. Overall, Bath & Body Works has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bath & Body Works' Cash Conversion Cycle compare to MNSO and RH?
Bath & Body Works' Cash Conversion Cycle of 35.60 can be compared against companies in the Retail - Cyclical industry. The industry median Cash Conversion Cycle is 69.06. Bath & Body Works' value of 35.60 is 48.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Retail - Cyclical company?
The median Cash Conversion Cycle among Retail - Cyclical companies is 69.06, based on 1,122 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bath & Body Works's current Cash Conversion Cycle of 35.60 is 48.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Bath & Body Works and its competitors. For the Retail - Cyclical industry, the median Cash Conversion Cycle is 69.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bath & Body Works's current Cash Conversion Cycle is 35.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bath & Body Works stock overvalued right now?
Based on GuruFocus' analysis, Bath & Body Works (WBO:LBRA) is currently considered Significantly Undervalued. The stock's GF Value™ is €29.16, compared to a current price of €18.79 — trading 35.6% below its estimated fair value. The current Cash Conversion Cycle is 35.60 and 48.5% below the Retail - Cyclical industry median of 69.06. Bath & Body Works' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Bath & Body Works (WBO:LBRA), the current Cash Conversion Cycle is 35.60 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bath & Body Works (WBO:LBRA) Overvalued in 2026?

Based on GuruFocus' analysis, Bath & Body Works stock appears to be undervalued. The current stock price of €18.79 is trading 35.6% below its estimated GF Value™ of €29.16. GuruFocus considers Bath & Body Works to be Significantly Undervalued.

Key valuation signals for WBO:LBRA:

  • Cash Conversion Cycle: 35.60
  • GF Value™: €29.16 vs. price of €18.79 (35.6% below fair value)
  • GF Score™: 62/100 with 4 warning signs
  • Industry Position: 48.5% below the Retail - Cyclical median

No single metric tells the full story. See the WBO:LBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bath & Body Works Business Description

Address Three Limited Parkway, Columbus, OH, USA, 43230
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
62GF Score

Get the complete analysis for WBO:LBRA

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.79
Price
€29.16
GF Value